Has Kevin Rehak, OD received payments from drug or device companies?

Yes. Drug and device makers reported $2,311 in general payments to Kevin Rehak, OD across 42 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kevin Rehak, OD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kevin Rehak, OD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kevin Rehak, OD

Optometrist · Royersford, PANPI 1063417202

Payments from drug & device makers

$2,311in general payments, 2019–2025

Across 42 payments — averaging $55.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Coopervision Inc.$2K
Alcon$337
Bausch & Lomb, A Division Of Bausch Health US, LLC$103
Bausch & Lomb Americas Inc.$77
Visioneering Technologies, Inc.$65
Johnson & Johnson Vision Care, Inc.$51
plus $13 from 1 others

What the payments were for

Food & beverage$1,11148%
Education$1,20052%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Coopervision Inc.	24	$1,664
Alcon	9	$337
Bausch & Lomb, A Division Of Bausch Health US, LLC	2	$103
Bausch & Lomb Americas Inc.	2	$77
Visioneering Technologies, Inc.	2	$65
Johnson & Johnson Vision Care, Inc.	2	$51
Novartis	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,311 in reported general payments places this provider in the 80th percentile of 2,165 optometrist providers in Pennsylvania.

See all optometrist providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$74,485

Medicare patients

423

Services billed

834

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Latanoprost	98	$737
Tobramycin-DexamethasoneTobramycin/Dexamethasone	11	$306
Cephalexin	11	$32

Paid to pharmacies, not to this prescriber.

Other optometrist in Royersford

James DeomHazle Township$793K
Gregory CaldwellDuncansville$547K
Glenn CorbinWyomissing$426K
Leslie O DellNew Freedom$409K
Kevin BistlinePlymouth Meeting$302K
Thomas KislanStroudsburg$267K
Erick HendersonPittsburgh$266K
Natasha HindmanCranberry Twp$179K
Ryan YealyLancaster$164K
Michael CymborState College$158K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →